+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology; Type; Indication; End User, and Country

  • ID: 5204887
  • Report
  • October 2020
  • Region: Asia Pacific
  • 174 pages
  • The Insight Partners
UP TO OFF
until Jun 30th 2021
1 of 3

FEATURED COMPANIES

  • Aduro Biotech Inc
  • AstraZeneca
  • Bristol-Myers Squibb
  • GlaxoSmithKline plc.
  • MaxiVAX
  • Moderna, Inc.
  • MORE
Cancer Vaccines Market for Dendritic Cells Cancer Vaccines Segment to Grow at Fastest CAGR during Forecast Period

According to the new market research study on “Cancer Vaccines Market to 2027 - Asia Pacific Analysis and Forecast - by Technology, Type, Indication, and End Use” the market is expected to reach US$3,131.09 million in 2027 from US$861.55 million in 2019; it is estimated to grow at a CAGR of 17.9% from 2020 to 2027. The report highlights trends prevailing in the Asia Pacific Cancer Vaccines Market and the drivers and restraints pertaining to the market growth.

Based on technology, the Cancer Vaccines market is segmented into in dendritic cells cancer vaccines, recombinant cancer vaccines, antigen cancer vaccines, whole cell cancer vaccines, viral vector cancer vaccines. The in recombinant cancer vaccines segment held the largest share of the market in 2019. Moreover, recombinant cancer vaccines is estimated grow at the highest CAGR in the market during the forecast period.

The Asia Pacific Cancer Vaccines market growth is mainly attributed to factors such as growing prevalence of cancer, and rising government initiatives to prevent it. However, the challenges in cancer vaccines industry like expensive cost restrains the growth of the market.

AstraZeneca, GlaxoSmithKline plc., Aduro Biotech Inc, Pfizer Inc., Sanofi, Bristol-Myers Squibb, Moderna, Inc., OncBioMune Pharmaceuticals Inc., MaxiVAX, Nouscom are among the leading companies operating in the Cancer Vaccines Market.

The report segments Asia Pacific Cancer Vaccines market as follows:

By Technology
  • Dendritic Cells Cancer Vaccines
  • Recombinant Cancer Vaccines
  • Antigen Cancer Vaccines
  • Whole Cell Cancer Vaccines
  • Viral Vector Cancer VaccinesBy Type
  • Preventive Cancer Vaccines
  • Therapeutic Cancer VaccineBy Indication
  • Cervical Cancer
  • Prostate Cancer
  • Other IndicationsBy End-Use
  • Pediatrics
  • AdultsBy Country
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of APAC
Reasons to Buy
  • It provides an understanding of the Asia Pacific Cancer Vaccines market landscape and identifies Cancer Vaccines market segments that are most likely to guarantee a strong return.
  • Stay ahead of the race by comprehending the ever-changing competitive market landscape.
  • It helps efficiently plan merger and acquisition, and partnership deals in the Cancer Vaccines market in Asia Pacific by identifying market segments with the most promising probable sales.
  • It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of the market performance of various segments.
  • It provides revenue forecast of the market based on various segments for the period from 2019 to 2027.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Aduro Biotech Inc
  • AstraZeneca
  • Bristol-Myers Squibb
  • GlaxoSmithKline plc.
  • MaxiVAX
  • Moderna, Inc.
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Cancer Vaccines Market - By Technology
1.3.2 Asia Pacific Cancer Vaccines Market - By Type
1.3.3 Asia Pacific Cancer Vaccines Market - By Indication
1.3.4 Asia Pacific Cancer Vaccines Market- By End Use
1.3.5 Asia Pacific Cancer Vaccines Market- By Region

2. Cancer Vaccines Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Cancer Vaccines - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinion

5. Asia Pacific Cancer Vaccines Market - Industry Dynamics
5.1 Key Drivers
5.1.1 Increase in Prevalence of Cancer Worldwide
5.1.2 Initiatives Taken by Global Health Research Organizations and Key Players for Cancer Vaccines
5.2 Key Market Restraints
5.2.1 Less Number of Commercially Available Vaccines for Treatment of Cancer
5.2.2 Higher Cost of Cancer Vaccines
5.3 Key Market Opportunities
5.3.1 Emerging Markets in Developing Countries
5.4 Future Trends
5.4.1 Growing Research and Development Activities
5.5 Impact analysis

6. Cancer Vaccines Market - Regional Analysis
6.1 Asia Pacific Cancer Vaccines Market Revenue Forecast And Analysis

7. Asia Pacific Cancer Vaccines Market Analysis - By Technology
7.1 Overview
7.2 Cancer Vaccines Market Share, by Technology, 2019 and 2027 (%)
7.3 Dendritic Cells Cancer Vaccine
7.3.1 Overview
7.3.2 Dendritic Cells Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Recombinant Cancer Vaccines
7.5.1 Overview
7.5.2 Recombinant Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Antigen Cancer Vaccines
7.6.1 Overview
7.6.2 Antigen Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
7.7 Whole Cell Cancer Vaccines
7.7.1 Overview
7.7.2 Whole Cell Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
7.8 Viral Vector Cancer Vaccines
7.8.1 Overview
7.8.2 Viral Vector Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)

8. Cancer Vaccines Market Analysis - By Type
8.1 Overview
8.2 Cancer Vaccines Market Revenue Share, by Type (2019 and 2027)
8.3 Preventive Cancer Vaccines
8.3.1 Overview
8.3.2 Preventive Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Therapeutic Cancer Vaccines
8.4.1 Overview
8.4.2 Therapeutic Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)

9. Cancer Vaccines Market Analysis - By Indication
9.1 Overview
9.2 Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027)
9.3 Cervical Cancer
9.3.1 Overview
9.3.2 Cervical Cancer: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Prostate Cancer
9.4.1 Overview
9.4.2 Prostate Cancer: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Other Indications
9.5.1 Overview
9.5.2 Other Indications: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)

10. Cancer Vaccines Market Analysis - By End Use
10.1 Overview
10.2 Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027)
10.3 Pediatrics
10.3.1 Overview
10.3.2 Pediatrics: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
10.4 Adults
10.4.1 Overview
10.4.2 Adults: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)

11. Cancer Vaccines Market - Geographic Analysis
11.1 Asia Pacific: Cancer Vaccines Market
11.1.1 Overview
11.1.2 Asia Pacific: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.3 Asia Pacific: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.1.4 Asia Pacific: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.1.5 Asia Pacific: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.1.6 Asia Pacific: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.1.7 Asia Pacific: Cancer Vaccines Market, by Country, 2019 & 2027 (%)
11.1.8 China: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.1 China: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.2 China: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.1.8.3 China: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.1.8.4 China: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.1.8.5 China: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.1.9 Japan: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Japan: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Japan: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.1.9.3 Japan: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.1.9.4 Japan: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.1.9.5 Japan: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.1.10 India: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.1 India: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.2 India: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.1.10.3 India: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.1.10.4 India: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.1.10.5 India: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.1.11 South Korea: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.11.1 South Korea: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.11.2 South Korea: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.1.11.3 South Korea: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.1.11.4 South Korea: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.1.11.5 South Korea: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.1.12 Australia: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.12.1 Australia: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.12.2 Australia: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.1.12.3 Australia: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.1.12.4 Australia: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.1.12.5 Australia: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)

12. Impact Of COVID-19 Pandemic On Global Cancer Vaccines Market
12.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic

13. Cancer Vaccines Market - Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview

14. Company Profiles
14.1 CSL Limited
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 ADURO BIOTECH INC.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Astellas Pharma Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Bristol-Myers Squibb Company
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 GlaxoSmithKline plc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Dendreon
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 AstraZeneca
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Merck & Co., Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Sanofi (Sanofi Pasteur)
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 OSE Immunotherapeutics
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix
15.1 Glossary of Terms


List of Tables
Table 1. Asia Pacific Cancer Vaccines Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 2. Asia Pacific Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 3. Asia Pacific Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
Table 4. Asia Pacific Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 5. China Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 6. China Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 7. China Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
Table 8. China Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 9. Japan Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 10. Japan Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 11. Japan Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
Table 12. Japan Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 13. India Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 14. India Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 15. India Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
Table 16. India Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 17. South Korea Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 18. South Korea Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 19. South Korea Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
Table 20. South Korea Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 21. Incidence, Mortality and Prevalence by cancer site, Australia, 2018
Table 22. Australia Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 23. Australia Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 24. Australia Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
Table 25. Australia Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 26. Organic Developments Done By Companies
Table 27. Inorganic Developments Done By Companies
Table 28. Glossary of Terms, Cancer Vaccines Market

List of Figures
Figure 1. Cancer Vaccines Market Segmentation
Figure 2. Cancer Vaccines Segmentation - By Region
Figure 3. Asia Pacific Cancer Vaccines Market Overview
Figure 4. In Recombinant Cancer Vaccines Segment Held Largest Share of Cancer Vaccines Market in 2019
Figure 5. Cancer Vaccines Market in Japan to Show Remarkable Growth During Forecast Period
Figure 7. Asia Pacific PEST Analysis
Figure 8. Cancer Statistics, 2020
Figure 9. Cancer Vaccines Market Impact Analysis of Driver and Restraints
Figure 10. Asia Pacific Cancer Vaccines Market - Revenue Forecast And Analysis - 2019-2027
Figure 11. Cancer Vaccines market Share, by Technology, 2019 and 2027 (%)
Figure 12. Dendritic Cells Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 13. Recombinant Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 14. Antigen Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 15. Whole Cell Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 16. Viral Vector Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 17. Cancer Vaccines Market Revenue Share, by Type (2019 and 2027)
Figure 18. Preventive Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 19. Therapeutic Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 20. Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027)
Figure 21. Cervical Cancer: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 22. Prostate Cancer: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 23. Other Indications: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 24. Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027)
Figure 25. Pediatrics: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 26. Adults: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 27. Asia Pacific: Cancer Vaccines Market, by Key Country - Revenue (2019) (USD Million)
Figure 28. Asia Pacific Cancer Vaccines Market Revenue and Forecast to 2027 (USD Million)
Figure 29. China: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 30. Japan: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 31. India: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 32. South Korea: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 33. Australia: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 34. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
Figure 35. Growth Strategies Done by the Companies in the Market, (%)
Note: Product cover images may vary from those shown
3 of 3
  • AstraZeneca
  • GlaxoSmithKline plc.
  • Aduro Biotech Inc
  • Pfizer Inc.
  • Sanofi
  • Bristol-Myers Squibb
  • Moderna, Inc.
  • OncBioMune Pharmaceuticals Inc.
  • MaxiVAX
  • Nouscom
Note: Product cover images may vary from those shown
Adroll
adroll